Shareholders Equity: The sum of preferred and common equity items.
CollPlant Biotechnologies Ltd. Sponsored ADR (CLGN) had Shareholders Equity of $2.94M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$0.11M |
|
$-2.73M |
|
$0.56M |
|
$-0.46M |
|
$2.74M |
|
$-2.63M |
|
$-0.09M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.73M |
|
$-2.63M |
|
$-2.44M |
|
1.44M |
|
1.44M |
|
$-1.89 |
|
$-1.89 |
|
| Balance Sheet Financials | |
$3.90M |
|
$1.05M |
|
$3.30M |
|
$7.20M |
|
$2.49M |
|
-- |
|
$1.77M |
|
$4.25M |
|
$2.94M |
|
$2.90M |
|
|
Shareholders Equity |
$2.94M |
1.44M |
|
| Cash Flow Statement Financials | |
$-5.38M |
|
$0.01M |
|
$2.34M |
|
$5.59M |
|
$2.56M |
|
$-3.03M |
|
$0.34M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.57 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-422.22% |
|
-2437.96% |
|
-2437.96% |
|
-- |
|
-2524.07% |
|
-2524.07% |
|
$-5.37M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
1.04 |
|
0.27 |
|
337.50 |
|
-92.56% |
|
-94.00% |
|
-37.88% |
|
-92.56% |
|
$2.04 |
|
$-3.72 |
|
$-3.73 |
|